DAIS CRAIG (Chief Financial Officer) received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/14/2023ACC: 0001415889-23-015095
Officer· Chief Financial Officer
Since Jul 2023
+973.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
973.63K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+973.63K
Price / share
—
Trade value
—
% of position
New position
11/10/2023
0.00→973.63K
Total
Net shares
+973.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2023 | A · Award | +973.63K | — | — | New position | 0.00 | 973.63K |
| Total | +973.63K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported